Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
News-Medical.Net on MSN4d
Dementia risk higher among adults with HIV in MalawiAdults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...
Mount Sinai researchers have developed a ... affecting nearly 40 million people globally. The findings were published in Nature Communications on March 6. HIV is a virus that attacks cells in ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
allAfrica.com on MSN4d
US funding cuts imperil search for HIV vaccineA group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...
The Punch on MSN1d
HIV doctors urge US to reverse 'catastrophic' funding cutsHundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback